Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients:

M C Foster1, D E Weiner1, A G Bostom2

  • 1Division of Nephrology, Tufts Medical Center, Boston, MA.

Insights

Cystatin C and beta-2-microglobulin (B2M) are better predictors of adverse outcomes like cardiovascular events, mortality, and kidney failure in kidney transplant recipients than creatinine. These filtration markers offer stronger prognostic value for transplant patient health.

Area of Science:

  • Nephrology
  • Transplantation Medicine
  • Cardiovascular Research

Background:

  • Cystatin C and beta-2-microglobulin (B2M) are established filtration markers linked to adverse outcomes in general populations.
  • Their predictive power may exceed that of creatinine, particularly in specific patient cohorts.
  • Kidney transplant recipients represent a population at high risk for cardiovascular events, mortality, and graft failure.

Purpose of the Study:

  • To evaluate the association of estimated glomerular filtration rate (eGFR) derived from cystatin C (eGFRcys) and B2M (eGFRB2M) with cardiovascular outcomes, mortality, and kidney failure.
  • To compare the prognostic utility of eGFRcys and eGFRB2M against traditional creatinine-based eGFR (eGFRcr) in stable kidney transplant recipients.
  • To determine if these associations persist after adjusting for baseline eGFRcr.

Main Methods:

  • A case-cohort study design was employed within the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
  • A random subcohort (N=508) was selected and enriched for cardiovascular events, mortality, and kidney failure.
  • Multivariable regression models were used to assess hazard ratios for adverse outcomes based on eGFR categories (<30 vs. 60+ mL/min/1.73m2).

Main Results:

  • Lower eGFRcys (<30) was associated with significantly increased risk for cardiovascular events (HR 2.02), mortality (HR 3.92), and kidney failure (HR 9.49) compared to eGFRcys 60+.
  • Similarly, lower eGFRB2M (<30) showed strong associations with cardiovascular events (HR 2.56), mortality (HR 4.09), and kidney failure (HR 15.53).
  • These associations remained significant even after adjusting for baseline eGFRcr, indicating independent prognostic value.

Conclusions:

  • Cystatin C and B2M-based eGFR are strongly associated with adverse cardiovascular outcomes, mortality, and kidney failure in stable kidney transplant recipients.
  • These markers demonstrate superior or complementary prognostic capability compared to creatinine-based eGFR in this high-risk population.
  • Incorporating cystatin C and B2M into risk assessment may improve management strategies for kidney transplant recipients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
611
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
419
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
469
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
81
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
545
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.6K